Epilepsy trials in Hungary
12 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleInvestigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
- Where
- Budapest
- Age
- 4 years to 55 years
- People
- 252 worldwide
- Run by
- SK Life Science, Inc.
See details and how to joinNCT05219617 - Phase 3Taking peopleA Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
- Where
- Budapest XIV
- Age
- 18 years and over
- People
- 360 worldwide
- Run by
- Xenon Pharmaceuticals Inc.
See details and how to joinNCT05716100 · EU 2022-502281-25-00 - Phase 3Enrolling by invitationAn Open-label Study of XEN1101 in Epilepsy
- Where
- Budapest XIV
- Age
- 12 years and over
- People
- 880 worldwide
- Run by
- Xenon Pharmaceuticals Inc.
See details and how to joinNCT05718817 · EU 2022-502282-24-00 - Phase 3Taking peopleA Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
- Where
- Budapest, Debrecen
- Age
- 2 years and over
- People
- 150 worldwide
- Run by
- Epygenix
See details and how to joinNCT04462770 · EU 2024-518628-57-00 - Phase 2Enrolling by invitationSPN-817 Open-Label Extension Study in Adults With Focal Onset Seizures
- Where
- DO NOT EDIT
- Age
- 18 years and over
- People
- 100 worldwide
- Run by
- Supernus Pharmaceuticals, Inc.
See details and how to joinNCT07141329 · EU 2026-526361-15-00 - Phase 3Taking peopleEfficacy and Safety Study of Once-Daily Extended-Release Levetiracetam in Drug-resistant Focal Onset Seizures
- Where
- Budapest, Budapest XIV, Eger
- People
- 134 worldwide
- Run by
- Neuraxpharm Pharmaceuticals S.L.
See details and how to join2024-514499-42-00 · EU 2024-514499-42-00 - Phase 3Taking peopleAn Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome
- Where
- Debrecen
- Age
- 2 years to 55 years
- People
- 260 worldwide
- Run by
- Epygenix
See details and how to joinNCT05066217 - Phase 2Taking peopleRENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
- Where
- Budapest
- Age
- 18 years to 70 years
- People
- 216 worldwide
- Run by
- Supernus Pharmaceuticals, Inc.
See details and how to joinNCT06798896 - Phase 2Taking peopleSPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults with Focal Onset Seizures
- Where
- Budapest, Budapest XIV
- Age
- 18 years and over
- People
- 110 worldwide
- Run by
- Supernus Pharmaceuticals Inc.
See details and how to join2025-520587-18-00 · EU 2025-520587-18-00 - Phase 3Taking peopleA Study to Test the Safety and Tolerability of Brivaracetam in Children and Adolescents With Seizures
- Where
- Budapest, Miskolc
- Age
- 1 month and over
- People
- 70 worldwide
- Run by
- UCB Biopharma SRL
See details and how to joinNCT04715646 - Phase 2Enrolling by invitationLong-term Safety and Tolerability of BHV-7000
- Where
- Budapest, Budapest XIV, Debrecen, Pécs
- Age
- 18 years to 75 years
- People
- 660 worldwide
- Run by
- Biohaven Therapeutics Ltd.
See details and how to joinNCT06443463 · EU 2023-508813-18-00 - No phaseTaking peopleSubcutaneous Intersectional Short Pulse Stimulation in Epileptic Patients
- Where
- Budapest
- Age
- 18 years to 65 years
- People
- 30
- Run by
- Semmelweis University
See details and how to joinNCT07041619